{
    "clinical_study": {
        "@rank": "129311", 
        "arm_group": {
            "arm_group_label": "Levodopa-Carbidopa Intestinal Gel", 
            "arm_group_type": "Experimental", 
            "description": "Single Arm, open label: Levodopa-Carbidopa Intestinal Gel"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to evaluate change in non-motor symptoms from\n      baseline to Week 12 as measured by the Non-Motor Symptom Scale total score."
        }, 
        "brief_title": "A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Advanced Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must have a diagnosis of idiopathic Parkinson's disease according to the\n             United Kingdom Parkinson's Disease Society (UKPDS) Brain Bank Criteria\n\n          -  Demonstrate persistent motor fluctuations in spite of individually optimized\n             treatment\n\n          -  Subject must experience a minimum of 3 hours \"Off\" time\n\n        Exclusion Criteria:\n\n          -  Subject's PD diagnosis is unclear or there is a suspicion that the subject has a\n             Parkinsonian syndrome such as secondary Parkinsonism (e.g., caused by drugs, toxins,\n             infectious agents, vascular disease, trauma, brain neoplasm), Parkinson-plus syndrome\n             (e.g., Multiple System Atrophy, Progressive Supranuclear Palsy, Diffuse Lewy Body\n             Disease, Corticobasilar Degeneration), or other neurodegenerative disease that might\n             mimic the symptoms of PD.\n\n          -  Subject has undergone neurosurgery for the treatment of Parkinson's disease\n\n          -  Subject for whom the placement of a PEG-J tube for LCIG treatment is contraindicated\n             or is considered a high risk for the PEG-J procedure according to the\n             gastroenterology evaluation (e.g., pathological changes of the gastric wall,\n             inability to bring the gastric wall and abdominal wall together, blood coagulation\n             disorders, peritonitis, acute pancreatitis, paralytic ileus)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736176", 
            "org_study_id": "M12-920"
        }, 
        "intervention": {
            "arm_group_label": "Levodopa-Carbidopa Intestinal Gel", 
            "description": "Dose levels will be individually optimized. Should be kept within a range of 0.5-10 ml/hour (10-200 mg levodopa/hour) and is usually 2-6 ml/hour (40-120 mg levodopa/hour).", 
            "intervention_name": "Levodopa-Carbidopa Intestinal Gel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Carbidopa", 
                "Levodopa", 
                "Carbidopa, levodopa drug combination"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "carbidopa", 
            "levodopa", 
            "Advanced Parkinson's disease", 
            "Safety and efficacy", 
            "levodopa-carbidopa intestinal gel,", 
            "Non-Motor Symptom Scale"
        ], 
        "lastchanged_date": "May 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294-0021"
                    }, 
                    "name": "Site Reference ID/Investigator# 85176"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 85176", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Encinitas", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92024"
                    }, 
                    "name": "Site Reference ID/Investigator# 66684"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 66684", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33486"
                    }, 
                    "name": "Site Reference ID/Investigator# 103155"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 103155", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32607"
                    }, 
                    "name": "Site Reference ID/Investigator# 82634"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 82634", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60190"
                    }, 
                    "name": "Site Reference ID/Investigator# 112857"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 112857", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "Site Reference ID/Investigator# 103156"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 103156", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40536"
                    }, 
                    "name": "Site Reference ID/Investigator# 66682"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 66682", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Bloomfield", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48322"
                    }, 
                    "name": "Site Reference ID/Investigator# 110115"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 110115", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45219"
                    }, 
                    "name": "Site Reference ID/Investigator# 82635"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 82635", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195-0001"
                    }, 
                    "name": "Site Reference ID/Investigator# 84453"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 84453", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kirkland", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98034"
                    }, 
                    "name": "Site Reference ID/Investigator# 89193"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 89193", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease", 
        "overall_contact": {
            "email": "wil.cramer@abbvie.com", 
            "last_name": "Willy  Cramer, MS"
        }, 
        "overall_contact_backup": {
            "email": "michelle.brueck@abbvie.com", 
            "last_name": "Michelle  Brueck, BS"
        }, 
        "overall_official": {
            "affiliation": "AbbVie", 
            "last_name": "Janet  Benesh, BS", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To assess changes in non-motor symptoms using Non-Motor Symptom Scale", 
            "safety_issue": "No", 
            "time_frame": "Baseline compared to Week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736176"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Collect  use of health resources (emergency room, doctors, urgent care, hospitals) with the Health Resource Utilization Questionnaire", 
                "measure": "Number of subjects who use health resources", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline compared to Week 4"
            }, 
            {
                "description": "Collect number and type of safety events with adverse event collection, vitals, and labs", 
                "measure": "Number of subjects who have Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline compared to \\ Week 60"
            }, 
            {
                "measure": "To assess changes in non-motor symptoms using Non-Motor Symptom Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline compared to Week 60"
            }, 
            {
                "measure": "To assess changes in motor symptoms using United Parkinson's Disease Rating Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline compared to Week 60"
            }, 
            {
                "measure": "To assess improvements in cognition using neurocognition assessments: Spatial Working Memory", 
                "safety_issue": "No", 
                "time_frame": "Baseline compared  to Week 12"
            }, 
            {
                "measure": "To assess changes in quality of life through: Parkinson's Disease Questionnaire-39 Item", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 60"
            }, 
            {
                "measure": "To assess changes in quality of life through: Patient Global Impression of Change", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 60"
            }, 
            {
                "measure": "To assess changes in quality of life through: Treatment Satisfaction Question", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 60"
            }, 
            {
                "measure": "To assess changes in quality of life through: Health-Related Productivity Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 60"
            }, 
            {
                "measure": "To assess changes in motor symptoms using Parkinson's Disease Diary", 
                "safety_issue": "No", 
                "time_frame": "Baseline compared to Week 60"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AbbVie (prior sponsor, Abbott)", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}